BODI Bodisen

Bodisen Biotech Inc
01 August 2007

1 August 2007



               Bodisen Biotech, Inc. ("Bodisen" or the "Company")

                                  Contract Win



Bodisen Biotech, Inc. (the "Company") (London AIM: BODI; OTC Pink Sheets: BBCZ;
website: www.bodisen.com) today announces its first export contract win.



The Company announces it has signed a contract with RADUGA Co., Ltd. through
Aoshen Imports and Exports Co., Ltd in the city of Huhehaote in the Inner
Mongolia Autonomous area for export to customers in Russia.  This contract is
for approximately 2.3 million RMB in products and represents the first
international export order for the Company.


Management Appointment


The Company also announces that Ms Junyan Tong, age 36, has been appointed to
serve as the Company's Chief Financial Officer  Ms Tong has previously served as
the Company's Assistant Chief Financial Officer since 2005.  This is not a main
board appointment.


From 1998 -2002, Ms Tong was Chief Financial Officer of Shenzhen Rongxun
Industry Co., Ltd., and between 1995- 1998, Ms Tong served as Financial Manager
of Guangdong Zhongyunhui Electric Co., Ltd.





About Bodisen Biotech, Inc.

Bodisen Biotech, Inc. is a leading manufacturer of liquid and organic compound
fertilizers, pesticides, insecticides and agricultural raw materials certified
by the Petroleum Chemical Industry Administrative office of China (Chemical
Petroleum Production Administrative Bureau), Shaanxi provincial government and
Chinese government.  The Company is headquartered in Shaanxi province and is a
Delaware corporation.  The Company's environmentally friendly "green" products
have been proven to improve soil and plant quality and increase crop yields.



Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of
the "safe harbor" provisions of the Private Securities Litigation Reform Act of
1995.  These statements are based on the current expectations or beliefs of
Bodisen Biotech, Inc. management and are subject to a number of factors and
uncertainties, and the outcome of events may differ materially from those
described in the forward-looking statements.



Enquiries:

Bodisen Investor Relations
Scott King - 001 219 939 3073
info@bodisen.com


Charles Stanley Securities (Nominated Adviser)
Rick Thompson / Philip Davies / Carl Holmes - 0207 149 6000


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NRAUAOARBRRWRAR

Bodisen Biotech (LSE:BODI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Bodisen Biotech (LSE:BODI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024